Our Health Care Litigation Team discusses a District of Massachusetts case holding that allows the government to switch liability theories in its False Claims Act lawsuit against Regeneron Pharmaceuticals....more
8/11/2025
/ Anti-Kickback Statute ,
Department of Justice (DOJ) ,
Discovery ,
False Claims Act (FCA) ,
Healthcare Fraud ,
Litigation Strategies ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
Regeneron ,
Summary Judgment
On February 4, the Wall Street Journal reported that the DOJ’s Fraud Section will now require companies to certify that they have “fully disclosed all information about individuals involved in wrongdoing before finalizing a...more
On September 9, 2015, the Department of Justice issued a memo (“Individual Accountability for Corporate Wrongdoing”) to federal prosecutors nationwide implementing new policies that—for the first time—prioritize the...more
9/14/2015
/ Attorney-Client Privilege ,
Compliance ,
Cooperation ,
Corporate Veil ,
Criminal Prosecution ,
Deferred Prosecution Agreements ,
Department of Justice (DOJ) ,
Enforcement Guidance ,
Individual Accountability ,
Internal Investigations ,
Investigations ,
Non-Prosecution Agreements ,
Personal Liability ,
Policy Statement ,
Professional Misconduct ,
Statute of Limitations ,
Upjohn Warnings ,
White Collar Crimes ,
Work-Product Doctrine